03 / Partnerships

From disease mechanism to drug pipeline

Built on the PerturbSeek ecosystem, we work with pharma, hospitals and research institutes on disease mechanism analysis, novel target discovery and new-modality drug development, and close the dry–wet loop in specific settings.

  • 01Disease mechanism analysis
  • 02Novel target discovery
  • 03New-modality drug development

Working together

Partnership models

Built on PerturbSeek, we partner in whichever way suits each organization, from subscribing to models to co-developing pipelines.

01

Service subscription

PerturbSeek model capabilities, on demand, as a subscription.

02

Private deployment

Light models like Flash, on site at hospitals, institutes and small pharma.

03

Pipeline co-development

High-value pipelines, from mechanism to new drug, in a dry–wet loop.

PharmaUniversitiesInstitutesHospitals

04

Research collaboration

Hospitals and academia, on complex diseases and unmet clinical needs.

How we work together

From biological question to experimental validation

01
DISEASE CONTEXT

Encode the disease state

A computable starting state.

02
VIRTUAL EXPERIMENT

Simulate before the bench

Forecast responses in silico.

03
DISCOVERY DECISION

Prioritize what to test

Focus resources on key validation.

04
LEARN

Every test sharpens the model

Data flow back in a dry–wet loop.

START A CONVERSATION

Let’s work together

Subscription, private deployment, pipeline co-development or research collaboration: we find the right fit.

Next chapter

04News